156 related articles for article (PubMed ID: 17367162)
1. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
Wempe MF; Wright C; Little JL; Lightner JW; Large SE; Caflisch GB; Buchanan CM; Rice PJ; Wacher VJ; Ruble KM; Edgar KJ
Int J Pharm; 2009 Mar; 370(1-2):93-102. PubMed ID: 19100824
[TBL] [Abstract][Full Text] [Related]
3. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.
Collnot EM; Baldes C; Schaefer UF; Edgar KJ; Wempe MF; Lehr CM
Mol Pharm; 2010 Jun; 7(3):642-51. PubMed ID: 20205474
[TBL] [Abstract][Full Text] [Related]
5. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
6. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Collnot EM; Baldes C; Wempe MF; Hyatt J; Navarro L; Edgar KJ; Schaefer UF; Lehr CM
J Control Release; 2006 Mar; 111(1-2):35-40. PubMed ID: 16410030
[TBL] [Abstract][Full Text] [Related]
7. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.
Zastre J; Jackson JK; Wong W; Burt HM
J Pharm Sci; 2007 Apr; 96(4):864-75. PubMed ID: 17094135
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
9. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
Li PY; Lai PS; Hung WC; Syu WJ
Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436
[TBL] [Abstract][Full Text] [Related]
10. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
Johnson BM; Charman WN; Porter CJ
AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
12. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
Wang AT; Liang DS; Liu YJ; Qi XR
Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
[TBL] [Abstract][Full Text] [Related]
13. [Recent advance in the mechanism study of polymeric inhibitors of P-glycoprotein].
Huang LM; Zhao JH; Wang GC; Zhou JP
Yao Xue Xue Bao; 2010 Oct; 45(10):1224-31. PubMed ID: 21348299
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity.
Zastre JA; Jackson JK; Wong W; Burt HM
Mol Pharm; 2008; 5(4):643-53. PubMed ID: 18380467
[TBL] [Abstract][Full Text] [Related]
15. Redefine the role of d-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance.
Chen JY; Sung CJ; Chen SC; Hsiang YP; Hsu YC; Teng YN
Eur J Pharm Sci; 2023 Nov; 190():106579. PubMed ID: 37689120
[TBL] [Abstract][Full Text] [Related]
16. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
Ke WT; Lin SY; Ho HO; Sheu MT
J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166
[TBL] [Abstract][Full Text] [Related]
17. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
[TBL] [Abstract][Full Text] [Related]
18. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
Hugger ED; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
Yu L; Bridgers A; Polli J; Vickers A; Long S; Roy A; Winnike R; Coffin M
Pharm Res; 1999 Dec; 16(12):1812-7. PubMed ID: 10644067
[TBL] [Abstract][Full Text] [Related]
20. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]